Objectives. The EQ-5D is a five-dimension multi-attribute questionnaire widely used to calculate quality-adjusted life-year scores. We aimed to describe patients with early arthritis (EA) and EQ-5D < 0, a state worse than death, at baseline and over 2 years and determine aspects of EA associated with a negative score.
Introduction
Given the scarcity of health care resources, public and private agencies are interested in the effectiveness and cost-effectiveness of health care interventions [1] . The preferred approach to measuring benefits in cost-effectiveness analysis is to measure health status by a single unit known as utilities. Utility values are used to calculate quality-adjusted life-years (QALYs), which are outcome measures that combine quantity and quality of life [2] . QALYs are the number of years of life in which a person is in a perfect state of health [3] . They are considered equivalent to years actually lived in a given health state multiplied by the utility value of that state. QALYs are used to assess the benefit of the health interventions in economic evaluations, such as costutility analysis. They are particularly informative for health policy decisions because they allow for direct comparison of the efficiency of health care resource expenditure across a wide range of conditions and treatments.
The utility concept was developed by health economists. Assessment of utility assigns a numeric value from 0 to 1 for health states, 0 indicating death and 1 a state of perfect health. The values reflect the preference for a health state in a situation of choice that includes uncertainty or sacrifice (e.g. life-years). Methods such as standard gamble and time trade-off may be used to measure health states directly, but they are less suitable for clinical research and less widely used for feasibility reasons. Therefore, indirect utility assessment techniques such as the EQ-5D [4] and SF-6D [5] have been developed. Indirect health utility assessments involve population-assigned weights to calculate utility scores for particular health states from multidomain health status questionnaires completed by patients [6] . These preference-based measures of health have become an important set of instruments for estimating health state values to calculate QALYs.
The EQ-5D [4] is an indirect preference-based health-related quality of life (HRQoL) instrument increasingly being used for economic evaluation of clinical interventions and health programmes. The EQ-5D consists of five items or dimensions (mobility, self-care, usual activity, pain/discomfort and anxiety/depression). Each dimension has three answer categories: 1, no problem; 2, some problems; or 3, severe problems. The combination of the five dimensions with the three answering categories produces 243 possible health states described as vectors ranging from 11 111 (no problems in any domain) to 33 333 (severe problems in all five domains) (e.g. 11 231 corresponds to no problems walking around, no problems with self-care, some problems with performing usual activities, extreme pain or discomfort and not anxious or depressed). The EQ-5D can be reported in terms of the five-digit profile representing the score on each dimension or in terms of a preference-based, single index number. The latter is calculated by applying algorithms that link the five-digit health state description to average values for members of the general population by the time trade-off method. The EQ-5D allows for negative utility values, which theoretically correspond to health states worse than death, not available with other indirect utility instruments (like SF-6D, etc.) [4] . We aimed to describe patients with EQ-5D < 0, a health state worse than death, in a multi-site cohort of patients with EA, at baseline and over 2 years, and to determine the aspects of EA associated with a state worse than death. [7] . Inclusion criteria were aged 1870 years, more than two swollen joints for >6 weeks and <6 months, suspected or confirmed diagnosis of RA, and not taking DMARDs or steroids (except if <2 weeks before inclusion). Patients were followed up every 6 months during the first 2 years. At baseline and at each visit we collected data on clinical and biological variables, including the DAS28 [8] . Furthermore, at each visit, patients completed self-administered patient-reported outcome questionnaires, including a functional ability questionnaire, the HAQ [9] and the HRQoL questionnaires, EQ-5D and the Short Form 36 (SF-36) Health Survey [10] . The SF-36 has eight dimensions with scores ranging from 0 (the worst HRQoL) to 100 (best HRQoL) summarized in two components assessing the physical dimension [physical component summary (PCS) score] and mental dimension [mental component summary (MCS) score], with scores transformed to have a mean of 50 and S.D. of 10 [10] . Low PCS and MCS indicate low physical and mental functioning, respectively. The protocol of the ESPOIR cohort study was approved by the ethics committee of Montpellier, France (approval number 020307). All patients gave their signed informed consent before inclusion.
Patients and methods

Patients
Utility measurement
The utility is calculated by applying algorithms that link the five-digit health state description to average values for members of the general population by the time trade-off method: 0 indicates death; 1 a state of perfect health; and negative (<0) utility indicates a state worse than death. EQ-5D reference indices were the French EQ-5D values derived from a population survey in France and involving 10-year time trade-off values [11] . Utility scores generated by the EQ-5D range from À0.53 to 1.
Statistical analysis
Utility scores and profiles of patients with a health state worse than death
We computed descriptive statistics (median, minimum, maximum and distribution) for patients with EQ-5D < 0 at baseline and the five-digit ED-5D profile scores for the five dimensions.
We investigated whether the mobility, pain or discomfort and anxiety or depression domains of the EQ-5D are valid measures of functional state, pain and psychological state in EA patients with EQ-5D < 0. We calculated the median HAQ score and PCS of the SF-36 for each of the three levels of the mobility domain; median pain at rest and during activities for each of the three levels of the pain/discomfort domain; and median MCS of the SF-36 for each of the three levels of the anxiety/depression domain. KruskalWallis test was used to evaluate differences among findings.
Determinants of health state worse than death
Multivariate logistic regression was used to determine specific aspects of EA independently associated with EQ-5D < 0 at baseline. We compared the characteristics and health status of patients with EQ-5D < 0 and EQ-5D 5 0 at baseline: qualitative variables were compared by chi-squared test or Fisher's exact test as appropriate and www.rheumatology.oxfordjournals.org
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Health state worse than death in EA quantitative variables with one-way analysis of variance or MannWhitney U-test as appropriate. A logistic regression model was then constructed with the dependent variable EQ-5D < 0 (yes/no) at baseline. The model entered candidate variables with a P-value <0.1 on bivariate analysis. If several outcomes had similar underlying constructs, only one was selected to avoid collinearity.
Several selection procedures (backward elimination, step-wise selection) were tested to check the robustness of the models. All analyses were repeated at 6, 12 and 24 months to check the stability of the model. Analyses involved the use of SAS v9.1 (SAS Institute, Cary, NC, USA). P < 0.05 was considered to be statistically significant.
Results
Characteristics of the population Table 1 shows the demographic and clinical characteristics of the 813 patients in the ESPOIR cohort at inclusion.
In total, 641 (78.8%) patients fulfilled the 2010 criteria of the ACR/European League Against Rheumatism (ACR/EULAR) for RA.
Utility scores
At baseline, 90 (11%) patients showed EQ-5D < 0, a health state worse than death. The median EQ-5D value was À0.052 (range À0.530 to À0.011). The number of patients at each level of the range gradually increased, with most patients having a score between À0.1 and 0 (Fig. 1) . Among 813 patients, there were five missing values for EQ-5D (14 for the DAS28, 2 for the patient global assessment, etc.).
Profile of patients with health state worse than death Patients exhibited 14 health profiles. Almost half of the patients with EQ-5D < 0 (46.7%) had the health profile 22 232: some or moderate problems with mobility, self-care, usual activities; extreme pain/discomfort and some or moderate anxiety/depression. The utility score for this state is À0.052. Almost all patients with EQ-5D < 0 had extreme pain/discomfort and at least moderate problems in usual activity (Fig. 2) . Fifty-three (59%) of these patients reported moderate and 36 (40%) extreme anxiety/depression. Most patients reported moderate problems in mobility (92%) and in self-care (91%). The same distribution of profiles was found at 6, 12 and 24 months, with 25 (3.3%), 23 (3.2%) and 24 (3.5%) patients, respectively, with EQ-5D < 0 (Fig. 3) . Of the 25 patients with a negative EQ-5D score at 6 months, 12 had a negative score at baseline. Of the 23 patients with a negative EQ-5D score at 12 months, 8 had a negative score at 6 months and only 5 patients had a negative score at all times. Of the 24 patients with a negative EQ-5D score at 2 years, 7 had a negative score at 1 year and 12 at baseline. Only three patients had a negative score at all times.
The SF-36 MCS significantly decreased with increasing anxiety/depression score (P = 0.005). The SF-36 PCS did not differ among mobility levels ( Table 2 ). The HAQ score increased but not significantly, with increasing mobility level (the number of patients was low in some levels).
Pain at rest increased with increasing pain/discomfort score but not significantly, and pain during daily activities did not differ by pain/discomfort level. Thus, the anxiety/ depression, mobility and pain/discomfort domains of the EQ-5D may have similar underlying constructs as the SF-36 MCS and, to a lesser extent, the HAQ score and pain at rest for patients with EQ-5D < 0.
Determinants of health state worse than death
Patients with EQ-5D < 0 had lower educational level, greater disease activity (DAS28), higher HAQ score (greater functional disability), lower SF-36 PCS and MCS, more pain at rest, fatigue and higher CRP levels than patients with EQ-5D 5 0 (all P < 0.001) ( Table 1) . We included level of education, DAS28, HAQ score, SF-36 MCS, pain at rest, fatigue and CRP level in the multivariate logistic regression model. Increased HAQ score and low SF-36 MCS (poor mental health) were independently associated with a negative EQ-5D score at baseline (Table 3) . Results were similar at 6, 12 and 24 months and with different variable selection procedures.
Discussion
This study is the first to examine in a real-life setting details of the health states of EA patients with state worse than death according to the EQ-5D utility measure and evolution over time. The disease's impact on pain, functional ability and mental component reflected in a state worse than death have consequences for the management of EA in these patients.
This health state was not rare; indeed, 11% of the ESPOIR cohort was in a state worse than death at the baseline measurement. This proportion was decreased at 6 months but remained stable over time, at 3.3%. Pain/discomfort was the key EQ-5D domain associated with a state worse than death and was extreme for most FIG. 2 Distribution of levels in each domain of the EQ-5D for patients with EA and health state worse than death (EQ-5D < 0) at baseline. 
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Health state worse than death in EA patients with EQ-5D < 0, especially at baseline. On multivariate analysis, the HAQ score and SF-36 MCS were independently and consistently associated with a state worse than death over 2 years. One of the strengths of this study is that we investigated data for a large group of patients with EA. The observational ESPOIR cohort study aimed to include patients with EA at all disease levels, age and sex, and here we found a significant proportion of EA patients in a real life setting in a health state worse than death by the EQ-5D. The study also included repeated measurement over 2 years with a large number of patients. Nevertheless, it should be noted that the worse than death utility prevalence in a general population matched for age and gender is unknown. The results must be interpreted in light of how the EQ-5D values are generated. The category worse than death is a researcher-generated artefact reflecting both the construction of the EQ-5D instrument and the perception of these health states by the general population. Macran et al. [12] identified a small group of subjects from a representative sample in the UK who, when given the option, chose to place relatively high value on the state death as compared with other health states. We do not know whether patients would agree to this definition of their health status, because the patient and population perception of burden of a disease can be discordant [13] . Investigating further the perception of patients and non-patients of health states by using qualitative research methods would be of interest. Our results were similar to those found for a more heterogeneous sample of patients with RA in a randomized control trial [14] . This previous study investigated baseline data from two UK trials: one of patients with inflammatory arthritis of <11 weeks' symptom duration and the other of patients with established (>5 years) symptomatic RA. However, the two groups were not differentiated in the analysis. Of 700 patients included, 9% were in a state worse than death and exhibited 9 of the possible 84 health profiles, with more than half (53%) exhibiting the same 22 232 health profile as we found. All patients presented severe pain/discomfort and moderate problems in three or more other domains. Adams et al. [15] found that for 345 patients with established RA, 17% had scores defined as worse than death at baseline and 7% at follow-up. Fewer patients with PsA showed this utility (12% at baseline and 2% at follow-up). Extreme pain scores were strongly associated with a state worse than death.
FIG. 3
This decrease in the proportion of patients in a state worse than death may reflect not only the beneficial effect of treatment, but also an adaptation over time to a new disease state. It should be noted that data were not available to determine whether some of the patients with a state worse than death had depression or fibromyalgia, or if any were treated for anxiety and depression.
The valuations of profiles vary by how sets of preference weights for health profiles were developed. The estimated value for 22 232 was À0.016 in the UK study [4] and À0.052 in the French study [11] ; this particular health profile was not rated worse than death in four other published EQ-5D valuations (USA, Denmark, Spain and Japan) [16] . The valuation of this health profile as worse than death for UK and French weights may be an artifact of the method used to estimate valuations for health profiles not directly valued by the general population sample but extrapolated from the other health profiles evaluated. However, the same preference-elicitation methodology was used in a Spanish study [16] , and a reduced study design was used in the Japan study [17] , for 17 hypothetical EQ-5D health states evaluated as compared with 42 in the UK study.
When assessed by clinical measures [e.g. swollen joint counts, pain on a visual analogue scale (VAS), functional disability], the health status of patients with a negative EQ-5D score was worse than for patients with EQ-5D 5 0 and these differences were important and probably clinically meaningful. Nevertheless, at the individual level, the variability of measured characteristics in patients with EQ-5D < 0 was large: pain at rest on a VAS from 0 to 100, fatigue from 20 to 100, PCS of the SF-36 from 12 to 48 and MCS of the SF-36 from 12 to 58, respectively. Moreover, the DAS28 ranged from 3.2 to 8.8, so patients with low disease activity can also present a state worse than death. This study demonstrated a dichotomy between perceived health and clinical status.
TABLE 3
Determinants of health state worse than death (EQ-5D < 0) at baseline and 6, 12 and 24 months by multivariate analysis for patients with EA Of the 24 patients with a negative EQ-5D score at 2 years, 7 had a negative score at 1 year and 12 at baseline. Only three patients had a negative score at all times, and these patients had very active disease at baseline. At 2 years, two of these three patients were in DAS28 remission but they all had high functional disability, fatigue and low mental health. So the EQ-5D < 0 reflected health state more than a personality feature.
Utilities measure the patient preference for health state by population-assigned weights, whereas HRQoL scales assess the patient assessment of functioning and well-being. Although these two concepts are related, they are not identical [18] , and measuring both may lead to a better understanding of health state in patients with a patient perspective and a mixed patient and societal perspective. According to the societal perspective, EA patients with a negative EQ-5D score should be a priority for health care: they have specific needs necessitating better management of pain and psychological state.
Rheumatology key messages
. High pain/discomfort was the key domain leading to states worse than death in EA. . High disability and mental distress are independent determinants of a state worse than death in EA. . EA patients have specific needs necessitating better management of pain and psychological state.
